GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Crism Therapeutics Corp (LSE:CRTX) » Definitions » Other Stockholders Equity

Crism Therapeutics (LSE:CRTX) Other Stockholders Equity : £-69.65 Mil (As of Jun. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Crism Therapeutics Other Stockholders Equity?

Crism Therapeutics's Other Stockholders Equity for the quarter that ended in Jun. 2024 was £-69.65 Mil.

Crism Therapeutics's quarterly Other Stockholders Equity declined from Jun. 2023 (£0.41 Mil) to Dec. 2023 (£-0.00 Mil) and declined from Dec. 2023 (£-0.00 Mil) to Jun. 2024 (£-69.65 Mil).

Crism Therapeutics's annual Other Stockholders Equity declined from Dec. 2021 (£-12.67 Mil) to Dec. 2022 (£-13.82 Mil) but then increased from Dec. 2022 (£-13.82 Mil) to Dec. 2023 (£-0.00 Mil).

Crism Therapeutics Other Stockholders Equity Historical Data

The historical data trend for Crism Therapeutics's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Crism Therapeutics Other Stockholders Equity Chart

Crism Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -9.32 -12.40 -12.67 -13.82 -

Crism Therapeutics Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.10 -13.82 0.41 - -69.65

Crism Therapeutics Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Crism Therapeutics Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Crism Therapeutics's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Crism Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Crism Therapeutics Corp (LSE:CRTX) » Definitions » Other Stockholders Equity
Comparable Companies
LSE:ROQ LSE:GENF LSE:VAL LSE:BSFA LSE:NFX LSE:TCF LSE:PYC LSE:ONC LSE:APTA AQSE:INC VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
Kingston Chambers, P.O. Box 173, Tortola, Road Town, VGB
Website
https://www.crismtherapeutics.com
Crism Therapeutics Corp has developed a drug delivery technology to improve the clinical performance of cancer treatments for solid tumours through the local delivery of chemotherapy drugs. Its product ChemoSeed which is in its clinical trial phase, can be implanted directly into the tumour or the resection margin following the removal of a tumour. The company also provides consultancy and formulation services to its clients assisting them with pharmaceutical formulation and development.

Crism Therapeutics Headlines

No Headlines